logotipo twitter link

Biobanking: a Gateway for Health seminar

back to list of events


Biobanking: a Gateway for Health: Future Direction for one of Europe’s Largest Health Research Infrastructures

On 18 November 2014, the pan-European Biobanking and BioMolecular resources Research Infrastructure – European Research Infrastructure Consortium (BBMRI-ERIC) will be organising a seminar in Brussels.

The seminar will focus on presenting BBMRI-ERIC, its contribution to the Innovation Union and its economic, scientific and health-related impact. A range of views and perspectives will be presented by multiple stakeholders, including the European Commission, the biotechnological and pharmaceutical sectors, research groups in universities, patients, and the legal sector.

BBMRI-ERIC will increase efficacy and excellence of European bio-medical research by:

  • facilitating access to quality-defined human health/disease-relevant biological resources, including associated data in an efficient and ethically and legally compliant manner,
  • reducing the fragmentation of the bio-medical research landscape through harmonisation of procedures, implementation of common standards and fostering high-level collaboration,
  • capacity building in countries with less developed biobanking communities thereby contributing to Europe's cohesion policy and strengthening the ERA.

The purpose of the seminar is to introduce BBMRI-ERIC and raise awareness of the significance of its research infrastructure. This meeting will also present an opportunity to illustrate the importance of evidence based policy making to representatives of the European Institutions, officials, industry, the research and wider stakeholder community, as well as to explore the potential interest of support.

Practical information:

Date: 18 November 2014

Time: 10:00-12:30

 Venue: Thon Hotel, Rue de la Loi 75, 1040 Bruxelles, Belgium

 Should you have any questions about your participation, please do not hesitate to contact Ms Leticia Bouges:



Media Enquiries

Jessica Hadjis

ISC Intelligence in Science

Email: jessica.hadjis@iscintelligence.com

Phone: +32 2 88 88 110

Mob: +32 487 163 107





Leticia Bouges

ISC Intelligence in Science

Email: leticia.bouges@iscintelligence.com 

Tel: +32 2 8888 108





On 3 December 2013, BBMRI was officially awarded the Community legal framework for a European Research Infrastructure Consortium (ERIC). This specific legal form is designed to facilitate the joint establishment and operation of research infrastructures of European interest. The ERIC status allows pulling together biobanks and biomolecular resources into a pan-European facility and providing access to collections of partner biobanks and biomolecular resources, their expertise and services on a non-economic basis. 

BBMRI-ERIC shall establish, operate and develop a pan-European distributed research infrastructure of biobanks and biomolecular resources in order to facilitate the access to resources as well as facilities and to support high quality biomolecular and medical research. BBMRI-ERIC operates on a non-economic basis. 

BBMRI-ERIC is set up as a distributed research infrastructrure in most, if not all European Member States. BBMRI-ERIC consists of 17 Member States, making it one of the largest research infrastructures in Europe. 

Members: Austria, Belgium, Czech Republic, Estonia, Finland, France, Germany, Greece, Italy, Malta, the Netherlands, Sweden

Observer Countries: Norway, Poland, Switzerland, Turkey, IARC/WHO





Topics & Speakers




Declan Kirrane (moderator)

Managing Director, ISC Intelligence in Science




Prof Jan-Eric Litton (Chair)

Director General, BBMRI-ERIC

“A Policy Basis for Biobanking in Europe and How BBMRI-ERIC will Deliver Innovation”




Prof Myriam Remmelink

Director, Biobank Council, Erasme-ULB

“The Legal Framework for Biobanks: Belgium”




Markus Pasterk

Administrative Director, BBMRI-ERIC

“BBMRI-ERIC  in a Global Setting: MOU with China”




Prof Dr Anu Jalanko

Head of Unit, Public Health Genomics Unit, National Institute for Health and Welfare (THL)

“The Importance of Biological Data to Find Links between Chronic-Disease Genomes, Environmental Factors and Lifestyles”




Dr Michaela Mayrhofer

Senior Project Manager, BBMRI-ERIC

“BBMRI-ERIC: Policy Challenges and Solutions for Excellent Research”







Dr Fatiha Sadallah (TBC)

Principal Scientific Manager, IMI

topic tbc



Erik Steinfelder

Biobanking Commercial Leader (EMEA), Thermo Fisher Scientific

“Truly sustainable personalised medicine – an industry perspective”




Gerrit Vandendriessche

Partner, Altius Brussels

“The Implications of the Data Protection Regulation for Life Sciences Research”




Dr Erik Briers

Executive Director, epposi Secretariat

“Patient Needs and BBMRI-ERIC in European Healthcare Policy”




Magda Chlebus

Director Science Policy, EFPIA

“A perspective on Industry Academia Precompetitive Collaboration and Innovation”




Helmut Walerius

Project Officer-EU policies, DG SANCO, European Commission

“Biobanking Support for Public Health”




Dr Georges Dagher 

Director,  French Infrastructure for Biobanks: BIOBANQUES, Inserm, France

“International standards for Biobanks are important for Biomedical Research and Precision Medicine”




Paul Tuinder

Legal Officer, Research Infrastructure, DG RTD, European Commission

“EU Research Infrastructure Priorities: BBMRI-ERIC Case Study”




Prof Dr Kurt Zatloukal (rapporteur)

Professor of Pathology, Institute of Pathology, Medical University of Graz

“BBMRI-ERIC in a Global Setting; Africa”





Q&A and Discussion

Declan Kirrane, Kurt Zatloukal (rapporteur), Jan-Eric Litton



End of Seminar